Search Results 2701-2710 of 16395 for Chronic Lymphocytic Leukemia

1. The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis - Mayo Clinic

   ... persistent cardiac dysfunction. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments ...

2. Publications - Thien Huynh, M.D. - Mayo Clinic

   Long-Term Safety and Efficacy of Pipeline Embolization Device in ... Chronic Headache Patients With and Without Nutcracker Physiology. J Comput ...

3. A Study to Assess Beta-Blocker Use in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Acute Myocardial Infarction - Mayo Clinic

   The purpose of this study is to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to ...

4. Tonic-Clonic (Grand Mal) Seizure Clinical Trials - Mayo Clinic Research

   Part B of this study will be conducted to evaluate the long-term safety and tolerability of GWP42003-P in participants with EMAS. A Study to Evaluate ...

5. Pyridorin in Diabetic Nephropathy - Mayo Clinic

   Participation eligibility · Patients with type 1 diabetes · Patients with a diagnosis of chronic kidney disease other than diabetic renal disease with or without ...

6. Toxicology and Pharmacology Shared Resource - Department of Molecular Medicine - Mayo Clinic Research

   ... lymphocytes, monocytes, neutrophils, basophils and eosinophils. It also provides the red blood cell (1012/L) and white blood cell (109/L) count, hemoglobin ...

7. Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study - Mayo Clinic

   Subject requires high level chronic immunomodulatory therapy to treat a moderate to severe chronic inflammatory autoimmune disorder. Subject is on an ...

8. Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

   Participation eligibility · History of liver disease such as cirrhosis, chronic active hepatitis, chronic persistent hepatitis or hepatitis B or C · Active ...

9. Monoclonal antibodies: Update on this COVID-19 experimental therapy - Mayo Clinic News Network

   But some are being developed from scratch to boost the initial immune response for patients who are at risk of severe COVID-19 disease. These experimental ...

10. A Study to Determine Recommended Dose, Regimen and Evaluate the Safety and Preliminary Effectiveness of CC-92480 in Combination With Standard Treatments in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) - Mayo Clinic

    Subject has plasma cell leukemia, Waldenstrom's ... History of severe coronary artery disease, severe ... Subject is positive for human immunodeficiency virus (HIV) ...